FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809569263> ?p ?o ?g. }

• W2809569263 abstract "Neonatal hypoxic-ischemic brain damage, characterized by tissue loss and neurologic dysfunction, is a leading cause of mortality and a devastating disease of the central nervous system. We have previously shown that vitexin has been attributed various medicinal properties and has been demonstrated to have neuroprotective roles in neonatal brain injury models. In the present study, we continued to reinforce and validate the basic understanding of vitexin (45 mg/kg) as a potential treatment for epilepsy and explored its possible underlying mechanisms. P7 Sprague-Dawley (SD) rats that underwent right common carotid artery ligation and rat brain microvascular endothelial cells (RBMECs) were used for the assessment of Na+-K+-Cl− co-transporter1 (NKCC1) expression, BBB permeability, cytokine expression, and neutrophil infiltration by western blot, q-PCR, flow cytometry (FCM), and immunofluorescence respectively. Furthermore, brain electrical activity in freely moving rats was recorded by electroencephalography (EEG). Our data showed that NKCC1 expression was attenuated in vitexin-treated rats compared to the expression in the HI group in vivo. Oxygen glucose deprivation/reoxygenation (OGD) was performed on RBMECs to explore the role of NKCC1 and F-actin in cytoskeleton formation with confocal microscopy, N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bromide, and FCM. Concomitantly, treatment with vitexin effectively alleviated OGD-induced NKCC1 expression, which downregulated F-actin expression in RBMECs. In addition, vitexin significantly ameliorated BBB leakage and rescued the expression of tight junction-related protein ZO-1. Furthermore, inflammatory cytokine and neutrophil infiltration were concurrently and progressively downregulated with decreasing BBB permeability in rats. Vitexin also significantly suppressed brain electrical activity in neonatal rats. Taken together, these results confirmed that vitexin effectively alleviates epilepsy susceptibility through inhibition of inflammation along with improved BBB integrity. Our study provides a strong rationale for the further development of vitexin as a promising therapeutic candidate treatment for epilepsy in the immature brain." @default.
• W2809569263 created "2018-06-29" @default.
• W2809569263 creator A5011144900 @default.
• W2809569263 creator A5036800142 @default.
• W2809569263 creator A5036920011 @default.
• W2809569263 creator A5043181509 @default.
• W2809569263 creator A5052368940 @default.
• W2809569263 creator A5071200615 @default.
• W2809569263 creator A5075980899 @default.
• W2809569263 creator A5078303301 @default.
• W2809569263 creator A5082356146 @default.
• W2809569263 creator A5088061646 @default.
• W2809569263 date "2018-06-20" @default.
• W2809569263 modified "2023-10-15" @default.
• W2809569263 title "Vitexin reduces epilepsy after hypoxic ischemia in the neonatal brain via inhibition of NKCC1" @default.
• W2809569263 cites W1555070356 @default.
• W2809569263 cites W1570478158 @default.
• W2809569263 cites W1830337612 @default.
• W2809569263 cites W1844869729 @default.
• W2809569263 cites W1971354794 @default.
• W2809569263 cites W1971883379 @default.
• W2809569263 cites W1977067061 @default.
• W2809569263 cites W1977291679 @default.
• W2809569263 cites W1986557899 @default.
• W2809569263 cites W1986729839 @default.
• W2809569263 cites W1993818398 @default.
• W2809569263 cites W1996037777 @default.
• W2809569263 cites W2000816152 @default.
• W2809569263 cites W2004284432 @default.
• W2809569263 cites W2005158904 @default.
• W2809569263 cites W2019787798 @default.
• W2809569263 cites W2022981588 @default.
• W2809569263 cites W2028383092 @default.
• W2809569263 cites W2040645020 @default.
• W2809569263 cites W2042937554 @default.
• W2809569263 cites W2047647123 @default.
• W2809569263 cites W2047841272 @default.
• W2809569263 cites W2049722015 @default.
• W2809569263 cites W2052792709 @default.
• W2809569263 cites W2057041797 @default.
• W2809569263 cites W2072419323 @default.
• W2809569263 cites W2076644208 @default.
• W2809569263 cites W2079121315 @default.
• W2809569263 cites W2080938528 @default.
• W2809569263 cites W2080962368 @default.
• W2809569263 cites W2081689918 @default.
• W2809569263 cites W2083146047 @default.
• W2809569263 cites W2089261234 @default.
• W2809569263 cites W2102748186 @default.
• W2809569263 cites W2110505481 @default.
• W2809569263 cites W2118687598 @default.
• W2809569263 cites W2121009504 @default.
• W2809569263 cites W2121212243 @default.
• W2809569263 cites W2122555934 @default.
• W2809569263 cites W2124029073 @default.
• W2809569263 cites W2129934770 @default.
• W2809569263 cites W2135122869 @default.
• W2809569263 cites W2136967026 @default.
• W2809569263 cites W2138989306 @default.
• W2809569263 cites W2142181855 @default.
• W2809569263 cites W2144802739 @default.
• W2809569263 cites W2149085480 @default.
• W2809569263 cites W2153507803 @default.
• W2809569263 cites W2162332184 @default.
• W2809569263 cites W2163935351 @default.
• W2809569263 cites W2166867187 @default.
• W2809569263 cites W2168602593 @default.
• W2809569263 cites W2176205911 @default.
• W2809569263 cites W2194155953 @default.
• W2809569263 cites W2220596386 @default.
• W2809569263 cites W2263957136 @default.
• W2809569263 cites W2320983896 @default.
• W2809569263 cites W2322559033 @default.
• W2809569263 cites W2345331808 @default.
• W2809569263 cites W2465302470 @default.
• W2809569263 cites W2515694737 @default.
• W2809569263 cites W2531859534 @default.
• W2809569263 cites W2584925516 @default.
• W2809569263 cites W2589962102 @default.
• W2809569263 cites W2605582901 @default.
• W2809569263 cites W2701436143 @default.
• W2809569263 cites W2783254727 @default.
• W2809569263 cites W2793043344 @default.
• W2809569263 cites W366478475 @default.
• W2809569263 cites W603663492 @default.
• W2809569263 cites W859391407 @default.
• W2809569263 cites W861690976 @default.
• W2809569263 doi "https://doi.org/10.1186/s12974-018-1221-6" @default.
• W2809569263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6011387" @default.
• W2809569263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29925377" @default.
• W2809569263 hasPublicationYear "2018" @default.
• W2809569263 type Work @default.
• W2809569263 sameAs 2809569263 @default.
• W2809569263 citedByCount "25" @default.
• W2809569263 countsByYear W28095692632018 @default.
• W2809569263 countsByYear W28095692632019 @default.
• W2809569263 countsByYear W28095692632020 @default.
• W2809569263 countsByYear W28095692632021 @default.
• W2809569263 countsByYear W28095692632022 @default.
• W2809569263 countsByYear W28095692632023 @default.

• next